| Literature DB >> 31569354 |
Christian Kohler1, Richard A Proctor2, Arnold S Bayer3,4, Michael R Yeaman5,6,7, Michael Lalk8, Susanne Engelmann9,10,11, Nagendra N Mishra12,13.
Abstract
We previously described a transposon mutant in Staphylococcus aureus strain SH1000 that exhibited reduced susceptibility to cationic thrombin-induced platelet microbicidal proteins (tPMPs). The transposon insertion site was mapped to the gene snoD, the staphylococcal nuo orthologue. Hence, further studies have been performed to understand how this mutation impacts susceptibility to tPMP, by comparing proteomics profiling and membrane lipid analyses of the parent vs. mutant strains. Surprisingly, the mutant showed differential regulation of only a single protein when cultivated aerobically (FadB), and only a small number of proteins under anaerobic growth conditions (AdhE, DapE, Ddh, Ald1, IlvA1, AgrA, Rot, SA2366, and SA2367). Corresponding to FadB impact on lipid remodeling, membrane fatty acid analyses showed that the snoD mutant contained more short chain anteiso-, but fewer short chain iso-branched chain fatty acids under both aerobic and anaerobic conditions vs. the parental strain. Based upon these proteomic and membrane compositional data, a hypothetical "network" model was developed to explain the impact of the snoD mutation upon tPMP susceptibility.Entities:
Keywords: S. aureus; lipids; proteomics; snoD mutant; tPMP resistance
Year: 2019 PMID: 31569354 PMCID: PMC6963496 DOI: 10.3390/antibiotics8040169
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Proteins of which the amount was affected by snoD mutation under anaerobic conditions.
| Protein (Annotation From 315) | Function | Ratio log2 (SH1000/snoD) |
|---|---|---|
|
| ||
| AdhE (SA0143) | Acetaldehyde DH | 1.46 |
| (SA2367) | Theoretical protein | 1.044 |
|
| ||
| DapE (SA1814) | Lysine metabolism | 1.021 |
| (SA2366) | Theoretical protein | 1.051 |
| AgrA (SA1844) | Virulence regulator | 1.287 |
|
| ||
| IlvA1 (SA1271) | Threonine/serine dehydrase | −4.17 |
| Ald1 (SA1272) | α-amino acid dehydrogenase | −1.667 |
| Ddh (SA2312) | D-lactate dehydrogenase | −1.006 |
Summary fatty acid compositional differences between parent and snoD mutant.
| Fatty Acid Species | SH1000-98 | * | SH1000-WT | * | ||
|---|---|---|---|---|---|---|
| Aerobic | Anaerobic | Aerobic | Anaerobic | |||
|
|
| 39.07 ± 0.49 | 0.006 | 61.16 ± 1.16 | 35.85 ± 1.10 | 0.002 |
|
| 3.58 ± 0.14 | 12.81 ± 0.16 | 0.0003 | 3.565 ± 0.40 | 12.10 ± 0.09 | 0.016 |
|
| 5.97 ± 0.08 | 14.69 ± 0.25 | 0.007 | 6.895 ± 0.13 | 16.60 ± 0.41 | 0.015 |
|
| 6.03 ± 0.05 | 5.205 ± 0.05 | 0.003 | 7.195 ± 0.08 | 5.30 ± 0.03 | 0.009 |
* p-value = aerobic vs. anaerobic.
Complete fatty acid analysis of strain-pair under aerobic and anaerobic conditions.
| Fatty Acid Species | Aerobic | Anaerobic | ||||
|---|---|---|---|---|---|---|
| SH1000-WT | SH1000-98 | SH1000-WT | SH1000-98 | |||
|
| - | 0.325 ± 0.01 | 0.265 ± 0.02 | |||
|
| - | 0.105 ± 0.01 | - | - | ||
|
| 1.18 ± 0.03 | 0.78 ± 0.01 | 0.01 | 1.985 ± 0.02 | 1.455 ± 0.04 | 0.007 |
|
| 0.215 ± 0.02 | 0.195 ± 0.01 | 1.07 ± 0.08 | 0.765 ± 0.011 | ||
|
| 0.165 ± 0.01 | 0.15 ± 0.00 | 0.325 ± 0.02 | - | ||
|
| 5.75 ± 0.11 | 5.185 ± 0.06 | 14.29 ± 0.42 | 12.97 ± 0.20 | ||
|
| 43.96 ± 0.72 | 46.15 ± 0.04 | 31.025 ± 0.93 | 33.495 ± 0.40 | ||
|
| - | - | 0.795 ± 0.05 | 0.31 ± 0.01 | 0.03 | |
|
| 3.05 ± 0.09 | 1.965 ± 0.06 | 0.009 | 1.17 ± 0.01 | 1.11 ± 0.01 | |
|
| 1.75 ± 0.10 | 1.81 ± 0.00 | 3.94 ± 0.16 | 3.98 ± 0.06 | ||
|
| - | - | 0.23 ± 0.01 | 0.205 ± 0.01 | ||
|
| 3.93 ± 0.07 | 3.55 ± 0.06 | 3.835 ± 0.01 | 3.695 ± 0.05 | ||
|
| 17.2 ± 0.44 | 18.24 ± 0.16 | 4.82 ± 0.17 | 5.57 ± 0.08 | 0.06 | |
|
| 0.215 ± 0.04 | 0.2 ± 0.01 | 2.075 ± 0.011 | 0.96 ± 0.04 | 0.02 | |
|
| 1.555 ± 0.01 | 1.02 ± 0.01 | 0.0025 | 0.395 ± 0.04 | 0.375 ± 0.04 | |
|
| 2.775 ± 0.04 | 3 ± 0.13 | 5.91 ± 0.03 | 6.13 ± 0.08 | ||
|
| 0.525 ± 0.01 | 0.58 ± 0.01 | 1.35 ± 0.03 | 1.515 ± 0.04 | ||
|
| 6.75±0.014 | 6.93 ± 0.08 | 10.4 ± 0.17 | 10.58 ± 0.00 | ||
|
| 1.335±0.01 | 1.185 ± 0.01 | 1.07 ± 0.01 | 1.135 ± 0.04 | ||
|
| 3.61 ± 0.04 | 3.68 ± 0.03 | 0.97 ± 0.04 | 1.225 ± 0.02 | 0.04 | |
|
| 0.245±0.04 | 0.235 ± 0.01 | 2.25 ± 0.18 | 1.145 ± 0.06 | ||
|
| 0.315± 0.01 | 0.415 ± 0.01 | 0.005 | 0.42 ± 0.01 | 0.49 ± 0.01 | 0.04 |
|
| 2.49 | - | 4.835 ± 0.04 | 5.165 ± 0.04 | ||
|
| 2.5 ± 0.056 | 2.615 ± 0.063 | 3.495 ± 0.08 | 4.055 ± 0.06 | 0.02 | |
|
| 0.375 ± 0.01 | 0.31 ± 0.014 | - | - | ||
* p-value = comparison between aerobic condition; ** p-value = comparison between anaerobic condition.
Figure 1Integrative hypothetical model of reduced tPMP susceptibility in S. aureus. This hypothetical model was derived from bioinformatics analysis and incorporates the data presented in this paper and previous work. This model illustrates how S. aureus can adapt to a phenotype that has reduced susceptibility to tPMP with a single mutation in snoD. Abbreviations used in figure: AdhE = alcohol-acetaldehyde dehydrogenase; Ald1 = α-amino acid dehydrogenase; DapE = succinyl-diaminopimelate desuccinylase; Ddh = D-lactate dehydrogenase; FadB = 3-hydroxyacyl-CoA dehydrogenase; IlvA1 = Threonine/serine dehydrase; PflB = formate acetyltransferase; snoD = S. aureus nuo orthologue; tPMP = thrombin-induced platelet microbicidal protein.